Peter Lynch · Growth at a reasonable price (GARP)
Is Aurinia Pharmaceuticals Inc. (AUPH) a Peter Lynch Stock?
Strong GARP candidate: growth at a reasonable price.
81/100
Fits
4/6 criteria passed
Peter Lynch's Criteria, Applied to AUPH
PEG ≤ 1.0
key-
EPS CAGR ≥ 15%
key-
Revenue CAGR ≥ 10%
57.8%
Net margin > 0
100.0%
How AUPH Scores on Other Strategies
Live Financial Snapshot
Market cap
$2.29B
P/E (TTM)
6.8x
ROIC (TTM)
18.99%
Gross margin
89.74%
Other Peter Lynch fit reports
Frequently Asked Questions
What is AUPH's Peter Lynch fit score?
AUPH scores 81/100 on our Peter Lynch fit engine. Strong GARP candidate: growth at a reasonable price.
Does Peter Lynch actually own AUPH?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends AUPH.
How often is this score updated?
AUPH's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends AUPH.
